Crimean-Congo Hemorrhagic Fever Virus Subunit Vaccines Induce High Levels of Neutralizing Antibodies But No Protection in STAT1 Knockout Mice

Jeroen Kortekaas, Rianka P M Vloet, Alexander J McAuley, Xiaoli Shen, Berend Jan Bosch, Laura de Vries, Rob J M Moormann, Dennis A Bente

    Research output: Contribution to journalArticleAcademicpeer-review

    Abstract

    Crimean-Congo hemorrhagic fever virus is a tick-borne bunyavirus of the Nairovirus genus that causes hemorrhagic fever in humans with high case fatality. Here, we report the development of subunit vaccines and their efficacy in signal transducer and activator of transcription 1 (STAT1) knockout mice. Ectodomains of the structural glycoproteins Gn and Gc were produced using a Drosophila insect cell-based expression system. A single vaccination of STAT129 mice with adjuvanted Gn or Gc ectodomains induced neutralizing antibody responses, which were boosted by a second vaccination. Despite these antibody responses, mice were not protected from a CCHFV challenge infection. These results suggest that neutralizing antibodies against CCHFV do not correlate with protection of STAT1 knockout mice.

    Original languageEnglish
    Pages (from-to)759-64
    Number of pages6
    JournalVector-Borne and Zoonotic Diseases
    Volume15
    Issue number12
    DOIs
    Publication statusPublished - Dec 2015

    Keywords

    • Crimean–Congo hemorrhagic fever virus
    • Bunyavirus
    • Nairovirus
    • Vaccine
    • Neutralizing antibodies
    • Gn
    • Gc
    • STAT1
    • STAT129

    Fingerprint

    Dive into the research topics of 'Crimean-Congo Hemorrhagic Fever Virus Subunit Vaccines Induce High Levels of Neutralizing Antibodies But No Protection in STAT1 Knockout Mice'. Together they form a unique fingerprint.

    Cite this